A commonly used prescription antidepressant medication is being recalled because it may contain a carcinogenic substance, the Food and Drug Administration announced.
New Jersey-based Breckenridge Pharmaceutical, Inc., is recalling 14,729 bottles of duloxetine delayed-release capsules in 30-milligram doses, contained in 1,000-count bottles, according to a notice that was published on the FDA’s recall database this week. The medication has an expiration date of April 2027 with a lot number of 241180C.
